Human vs Analogue Insulin in Young People With Type 1 Diabetes: What the HumAn-1 Trial Found 24th September 20267th July 2026 by Living Diabetes Editorial The HumAn-1 trial found no clear CGM advantage for glargine over usual-care human insulin regimens at 6 months in young people with type 1 diabetes.
